Literature DB >> 17412470

Support for selection of a methamphetamine cleanup standard in Colorado.

Tracy L Hammon1, Susan Griffin.   

Abstract

Methamphetamine production for illicit use occurs in makeshift labs and is associated with the release of numerous chemicals, including methamphetamine residues. These methamphetamine residues may pose a health risk to residents who reoccupy these structures after property seizures. Several states have established technology-based cleanup standards for methamphetamine, but none have examined the health-protectiveness of these standards. In response to Colorado House Bill 04-1182, exposure intakes correlated with three technology-based standards were calculated for various groups of individuals. Intakes were assessed for a 1-year-old infant, 6-year-old child, and a female of childbearing age. Exposure intakes were compared to toxicity reference values developed from developmental endpoints following methamphetamine exposure from the available literature. Uncertainty factors were applied to the lowest adverse effect levels observed in these studies to arrive at the toxicity reference values. These reference values were greater than the calculated intakes from each proposed technology standard, suggesting that all of the proposed standards would be protective of human health exposure. The cost and practicality of attaining each of the proposed standards was also factored into the decision making process. In their final regulation (6 CCR 1014-3), the CDPHE selected 0.5 microg/100 cm(2) as the final cleanup standard for methamphetamine residues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17412470     DOI: 10.1016/j.yrtph.2007.02.002

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  1 in total

Review 1.  Management of clandestine drug laboratories: need for evidence-based environmental health policies.

Authors:  Tamara A Al-Obaidi; Stephanie M Fletcher
Journal:  Environ Health Prev Med       Date:  2013-09-04       Impact factor: 3.674

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.